---  
layout: startup_page  
title: "RyboDyn"  
id: "rybodyn.com"  
permalink: "/rybodynrybodyn.com01092025/"  
website: "https://www.rybodyn.com"  
funding_round: "Pre-Seed"  
funding_amount: "$4M"  
investors: "Genedant Capital, SeaX Ventures, SOSV, Swell VC"  
about: "RyboDyn is a biotechnology company developing first-in-class immunotherapies targeting the dark genome. They utilize RyboCypher, a proprietary RNA sequencing technology, to identify and validate previously unknown proteins for use in novel cancer therapies. This approach offers a unique 'targets-to-assets' strategy for therapeutic development."  
markets: "Biotechnology, Cancer Immunotherapy, Medical, Pharmaceutical, Therapeutics, Drug Discovery, HealthTech"  
hq: "San Diego, California, United States"  
founded_year: "2022"  
linkedin: "https://www.linkedin.com/company/rybodyn"  
twitter: ""  
instagram: ""  
facebook: ""  
crunchbase: "https://www.crunchbase.com/organization/rybodyn"  
pitchbook: "https://pitchbook.com/profiles/company/498129-58"  

date_display: "09-Jan-2025"  
date: "2025-01-09"

# SEO Optimization  
meta_title: "RyboDyn - Pre-Seed Funding ($4M)"  
meta_description: "RyboDyn, RyboDyn is a biotechnology company developing first-in-class immunotherapies targeting the dark genome. They utilize RyboCypher, a proprietary RNA seq..."  
meta_keywords: "RyboDyn, Biotechnology, Cancer Immunotherapy, Medical, Pharmaceutical, Therapeutics, Drug Discovery, HealthTech, Pre-Seed funding"  
canonical_url: "https://startup.projectstartups.com/rybodynrybodyn.com01092025/"  
---